Connor, Clark & Lunn Investment Management (CC&L)
ABUS icon

Connor, Clark & Lunn Investment Management (CC&L)’s Arbutus Biopharma ABUS Stock Holding History

Connor, Clark & Lunn Investment Management (CC&L)’s Portfolio ABUS Stock Details ABUS Fund Activity
Quarter Market Value Status Shares Shares
Change % 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-13,268
Closed -$34.2K – 1347
2024
Q1 		$34.2K Buy
+13,268
New +$34.2K ﹤0.01% 1492
2022
Q4 		– Sell
-90,497
Closed -$173K – 1179
2022
Q3 		$173K Buy
+90,497
New +$173K ﹤0.01% 1006